Atrial fibrillation and flutter – the state of the art. Part 2

Agnieszka Janion-Sadowska; Łukasz Turek; Aneta Dudek; Jarosław Andrychowski; Marcin Sadowski

doi:10.5114/ms.2021.109530

eISSN: 2300-6722
ISSN: 1899-1874

Medical Studies/Studia Medyczne

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2021
vol. 37

Send email

Copy url:

abstract:

Review paper

Atrial fibrillation and flutter – the state of the art. Part 2

Agnieszka Janion-Sadowska

¹

,

Łukasz Turek

¹

,

Aneta Dudek

¹

,

Jarosław Andrychowski

¹

,

Marcin Sadowski

¹

Institute of Medical Sciences, Collegium Medicum, Jan Kochanowski University, Kielce, Poland

Medical Studies/Studia Medyczne 2021; 37 (3): 239–249

DOI: https://doi.org/10.5114/ms.2021.109530

Online publish date: 2021/09/30

View full text Get citation

PlumX metrics:

Despite constantly updating our knowledge on atrial fibrillation and flutter there are many questions and doubts about the nature and extent of arrhythmic and non-arrhythmic consequences of these arrhythmias. In part 1 of the state-of-the-art paper the diagnostic work-up of patients with the 2 arrhythmias was summarized. The management of patients with atrial fibrillation and flutter requires a multidisciplinary approach in the risk assessment (including stroke) and treatment strategy. Regardless of the type of antiarrhythmic or anticoagulant therapy, benefits must always surpass or at least offset potential adverse effects and drug toxicity. In part 2 of the state-of-the-art paper, current therapeutic strategies have been summarized.

keywords:

Atrial fibrillation and flutter – the state of the art. Part 2

Agnieszka Janion-Sadowska 1 , Łukasz Turek 1 , Aneta Dudek 1 , Jarosław Andrychowski 1 , Marcin Sadowski 1

treatment, risk, stroke, atrial fibrillation, atrial flutter

Agnieszka Janion-Sadowska

¹

,

Łukasz Turek

¹

,

Aneta Dudek

¹

,

Jarosław Andrychowski

¹

,

Marcin Sadowski

¹